Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Journal of Neuro-Oncology
|
November 1, 2023
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy
Stefanie Krassnig, Stefan L Leber, Andrea Orthmann, et al.
Neuro-Oncology
|
October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
Michael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.
Neuro-Oncology Advances
|
December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED database
Lara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Pediatric Blood & Cancer
|
November 18, 2015
Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes
Marie L Weber, Dominik T Schneider, Sonja Offenmüller, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
Stefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Pediatric Blood & Cancer
|
October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort
Martin Benesch, Karolina Nemes, Petra Neumayer, et al.
Journal of Neuro-Oncology
|
January 12, 2013
A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries
Daniel Satgé, Charles A Stiller, Stefan Rutkowski, et al.
Neuro-Oncology Advances
|
November 25, 2024
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry
Joshua N Baugh, Sophie Veldhuijzen van Zanten, Marta Fiocco, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial
Stefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
Birgitta Lannering, Stefan Rutkowski, Francois Doz, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Journal of Neuro-Oncology
|
November 1, 2023
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy
Stefanie Krassnig, Stefan L Leber, Andrea Orthmann, et al.
Neuro-Oncology
|
October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
Michael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.
Neuro-Oncology Advances
|
December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED database
Lara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Pediatric Blood & Cancer
|
November 18, 2015
Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes
Marie L Weber, Dominik T Schneider, Sonja Offenmüller, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
Stefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Pediatric Blood & Cancer
|
October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort
Martin Benesch, Karolina Nemes, Petra Neumayer, et al.
Journal of Neuro-Oncology
|
January 12, 2013
A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries
Daniel Satgé, Charles A Stiller, Stefan Rutkowski, et al.
Neuro-Oncology Advances
|
November 25, 2024
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry
Joshua N Baugh, Sophie Veldhuijzen van Zanten, Marta Fiocco, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial
Stefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
Birgitta Lannering, Stefan Rutkowski, Francois Doz, et al.
Page
of 16